The substantial benefits these medicines provide for diabetes control and weight management typically outweigh temporary side effects
We help you strategize around obstacles to achieve lasting success
"The people who have the greatest need for these medications are precisely the people who are in lower socioeconomic strata who have either poor insurance or no insurance, and dont have the discretionary funds to be spending on medications, Krumholz, a cardiologist and professor of medicine at Yale School of Medicine, told NBC News
Retail pricing at Canadian pharmacies as of April 2026:[1] Unlike Wegovy (flat pricing regardless of dose), Ozempic scales slightly with dose strength
The risk of nonarteritic anterior ischemic optic neuropathy (NAION) was not significantly different among those on GLP-1 drugs and those on other diabetes medicines
The Take-Away Its important to note that while many people report positive effects from MIC/B-12 injections, the evidence supporting these benefits is limited